Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 41

Results For "first"

3326 News Found

Happiest Health expands dental care footprint with its second Happiest Pearls Clinic
Healthcare | April 14, 2026

Happiest Health expands dental care footprint with its second Happiest Pearls Clinic

Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model


WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat
Public Health | April 14, 2026

WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat

Scientists at the forum warned of an increasingly volatile health landscape


Boehringer Ingelheim & BioNTech launch high-stakes lung cancer combo trial
Clinical Trials | April 14, 2026

Boehringer Ingelheim & BioNTech launch high-stakes lung cancer combo trial

BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study


India Pharma 2026 showcases sectoral transformation through four key plenary discussions
Policy | April 14, 2026

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals


FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review
Drug Approval | April 14, 2026

FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review

The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis


NASA’s Artemis II mission to on board Opella’s Dulcolax for lunar orbit mission
News | April 14, 2026

NASA’s Artemis II mission to on board Opella’s Dulcolax for lunar orbit mission

A brand from Opella will be part of the official NASA astronaut formulary


AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial
Clinical Trials | April 14, 2026

AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial

Highlights Mirvetuximab-based regimen promise


Sun Pharma unveils new brand film highlighting shared ‘No. 1’ spirit with Royal Challengers Bengaluru
News | April 14, 2026

Sun Pharma unveils new brand film highlighting shared ‘No. 1’ spirit with Royal Challengers Bengaluru

The campaign builds on the three-year partnership unveiled earlier this season


ICPA to host India Unlimited 4.0 in San Diego to spotlight India’s global biopharma role
Biopharma | April 13, 2026

ICPA to host India Unlimited 4.0 in San Diego to spotlight India’s global biopharma role

This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing


TARC Tripundra launches in-community medical facility with Fortis Gurugram
Hospitals | April 13, 2026

TARC Tripundra launches in-community medical facility with Fortis Gurugram

On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents